Morning Stock Market News 25 February ::
MARKET COMMENTARY
The market is likely to open higher on mostly positive Asian stocks. Trading of CNX Nifty futures on the Singapore stock exchange indicates that the Nifty could gain 23 points at the opening bell. Most Asian stocks rose tracking overnight gains from Wall Street.
Cadila Healthcare announced after market hours on Monday, that it has received the final approval from the USFDA to market Clonidine Hcl Injection 0.1 & 0.5 mg/ml, 10 ml in the United States. Cadila Healthcare said that the company now has 90 approvals & has so far filed 216 ANDAs since the commencement of filing process in FY 2003-04.
The market may remain volatile as traders roll over positions in the futures & options (F&O) segment from the near-month February 2014 series to March 2014 series. The near month February 2014 F&O contracts expire tomorrow, 26 February 2014.
Foreign institutional investors (FIIs) bought shares worth a net Rs 266.87 crore on Monday, 24 February 2014, as per provisional data from the stock exchanges.
US stocks climbed on Monday, boosted by M&A activity, an upbeat German confidence report & bets that the S&P 500′s foray into new high ground could spur further buying. The Federal Open Market Committee (FOMC) next undertakes monetary policy review on 18-19 March 2014. Read More Info http://research4u.co.in/intraday_stock_com...ws-25-february/
Intraday Equity Tips